Quick Answer
Journey Medical Corp reported Stockholders Equity of $31.85 million for fiscal year 2025.
Journey Medical Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $31.85M | +58.7% |
| 2024 | $20.07M | -1.4% |
| 2023 | $20.35M | +19.8% |
| 2022 | $16.98M | -59.6% |
| 2021 | $42.04M | +308.5% |
| 2020 | $10.29M | +274.0% |
| 2019 | $2.75M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $25.90M | +137.0% | +34.6% |
| June 30, 2025 | $19.25M | +70.4% | -10.7% |
| March 31, 2025 | $21.54M | +66.3% | +7.3% |
| December 31, 2024 | $20.07M | -1.4% | +83.7% |
| September 30, 2024 | $10.93M | -37.1% | -3.3% |
| June 30, 2024 | $11.29M | +225800.0% | -12.8% |
| March 31, 2024 | $12.95M | +72.9% | -36.4% |
| December 31, 2023 | $20.35M | +19.8% | +17.1% |
- Journey Medical Corp showed an increase of +58.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Journey Medical Corp’s stockholders equity has grown by 1057.4% (from $2.75 million to $31.85 million).
- The most recent figure is from Journey Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: